This is a table of type unigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
unigram | frequency |
---|---|
patients | 21218 |
cells | 10071 |
cell | 9034 |
cd | 7897 |
disease | 5953 |
transplantation | 5523 |
transplant | 5332 |
infection | 5229 |
cmv | 4721 |
treatment | 4718 |
hsct | 4476 |
median | 3965 |
results | 3811 |
gvhd | 3747 |
risk | 3704 |
study | 3608 |
donor | 3583 |
patient | 3528 |
der | 3443 |
years | 3435 |
group | 3349 |
infections | 3337 |
therapy | 3335 |
days | 3302 |
die | 3291 |
virus | 3284 |
stem | 3275 |
associated | 3216 |
may | 3165 |
months | 3150 |
high | 3077 |
und | 3020 |
clinical | 2928 |
day | 2856 |
time | 2844 |
survival | 2812 |
acute | 2810 |
recipients | 2760 |
one | 2755 |
age | 2706 |
blood | 2676 |
received | 2638 |
immune | 2635 |
also | 2603 |
mg | 2547 |
pts | 2530 |
vs | 2494 |
graft | 2462 |
using | 2398 |
analysis | 2395 |
used | 2380 |
response | 2299 |
il | 2269 |
allogeneic | 2226 |
post | 2223 |
two | 2221 |
viral | 2198 |
compared | 2187 |
range | 2176 |
data | 2135 |
methods | 2132 |
specific | 2078 |
kg | 2053 |
relapse | 2049 |
severe | 2048 |
human | 2046 |
cases | 2021 |
non | 1996 |
first | 1983 |
respectively | 1979 |
conditioning | 1952 |
year | 1936 |
diagnosis | 1932 |
however | 1928 |
significant | 1924 |
expression | 1921 |
i | 1902 |
related | 1871 |
chronic | 1863 |
dose | 1833 |
mortality | 1819 |
incidence | 1795 |
levels | 1768 |
performed | 1763 |
prophylaxis | 1755 |
increased | 1738 |
due | 1731 |
anti | 1728 |
higher | 1691 |
based | 1664 |
use | 1642 |
well | 1639 |
hiv | 1628 |
significantly | 1622 |
donors | 1620 |
treated | 1607 |
observed | 1601 |
hla | 1580 |
children | 1580 |
bei | 1578 |
showed | 1565 |
positive | 1555 |
marrow | 1551 |
hematopoietic | 1543 |
early | 1533 |
sct | 1522 |
low | 1516 |
von | 1515 |
without | 1506 |
primary | 1500 |
renal | 1492 |
follow | 1492 |
mice | 1445 |
mit | 1442 |
os | 1436 |
found | 1428 |
bone | 1423 |
studies | 1410 |
overall | 1408 |
conclusions | 1404 |
following | 1402 |
including | 1397 |
liver | 1389 |
number | 1386 |
reported | 1379 |
eine | 1373 |
allo | 1368 |
developed | 1362 |
lung | 1352 |
ci | 1341 |
groups | 1341 |
different | 1339 |
regimen | 1339 |
function | 1333 |
factors | 1330 |
rate | 1324 |
pneumonia | 1307 |
ist | 1275 |
ml | 1273 |
syndrome | 1271 |
pcr | 1263 |
failure | 1257 |
cr | 1239 |
respiratory | 1234 |
grade | 1232 |
hct | 1219 |
background | 1213 |
reduced | 1207 |
role | 1205 |
outcome | 1198 |
versus | 1196 |
control | 1188 |
type | 1179 |
total | 1167 |
peripheral | 1151 |
dna | 1147 |
antibody | 1140 |
negative | 1139 |
effect | 1130 |
gene | 1106 |
common | 1105 |
lower | 1099 |
disclosure | 1096 |
antigen | 1093 |
present | 1087 |
ebv | 1087 |
among | 1085 |
diseases | 1084 |
host | 1084 |
engraftment | 1082 |
reactivation | 1075 |
aml | 1073 |
three | 1071 |
development | 1069 |
unrelated | 1064 |
organ | 1059 |
included | 1045 |
within | 1043 |
case | 1043 |
pre | 1040 |
protein | 1030 |
cause | 1027 |
normal | 1027 |
complications | 1026 |
rejection | 1025 |
agvhd | 1019 |
long | 1017 |
leukemia | 1014 |
antibodies | 1005 |
matched | 999 |
cytomegalovirus | 991 |
infectious | 980 |
although | 973 |
outcomes | 968 |
important | 955 |
single | 951 |
werden | 950 |
identified | 950 |
term | 949 |
igg | 941 |
autologous | 940 |
activation | 940 |
infected | 923 |
period | 922 |
analyzed | 922 |
nk | 917 |
second | 915 |
ii | 915 |
effects | 915 |
samples | 914 |
activity | 911 |
free | 906 |
atg | 898 |
en | 891 |
increase | 888 |
shown | 887 |
prior | 881 |
level | 875 |
serum | 874 |
presence | 871 |
zu | 868 |
transplanted | 868 |
kidney | 866 |
hepatitis | 861 |
recipient | 858 |
induced | 856 |
sind | 855 |
complete | 853 |
im | 850 |
oder | 849 |
cohort | 848 |
population | 847 |
given | 841 |
potential | 840 |
mean | 837 |
hospital | 837 |
followed | 836 |
responses | 827 |
factor | 823 |
similar | 822 |
status | 821 |
multiple | 819 |
fever | 817 |
none | 815 |
test | 809 |
major | 808 |
considered | 807 |
es | 805 |
viruses | 799 |
iv | 799 |
impact | 798 |
center | 797 |
underwent | 795 |
lymphoma | 793 |
effective | 793 |
inflammatory | 790 |
asct | 788 |
einer | 785 |
skin | 780 |
system | 779 |
immunodeficiency | 777 |
table | 767 |
production | 765 |
new | 760 |
pediatric | 757 |
receptor | 756 |
haploidentical | 756 |
addition | 756 |
weeks | 752 |
death | 751 |
symptoms | 750 |
according | 747 |
induction | 747 |
report | 740 |
refractory | 740 |
will | 739 |
model | 738 |
pulmonary | 736 |
phase | 733 |
chemotherapy | 729 |
less | 724 |
interest | 723 |
detected | 723 |
rates | 722 |
occurred | 720 |
vaccine | 715 |
died | 711 |
vitro | 707 |
infants | 706 |
ifn | 705 |
either | 704 |
mm | 704 |
influenza | 702 |
standard | 700 |
vivo | 699 |
several | 698 |
nach | 695 |
evidence | 694 |
remission | 689 |
cgvhd | 686 |
bacterial | 686 |
des | 678 |
cord | 674 |
immunosuppression | 673 |
evaluated | 673 |
lymphocytes | 671 |
durch | 665 |
diagnosed | 664 |
receiving | 664 |
demonstrated | 663 |
secondary | 660 |
conclusion | 658 |
transplants | 658 |
adult | 656 |
revealed | 653 |
detection | 650 |
deficiency | 649 |
known | 647 |
efficacy | 642 |
care | 641 |
lymphocyte | 641 |
available | 640 |
progression | 639 |
healthy | 637 |
per | 633 |
hr | 631 |
presented | 628 |
das | 628 |
transmission | 624 |
recovery | 623 |
regimens | 621 |
difference | 620 |
toxicity | 620 |
since | 619 |
trial | 615 |
four | 615 |
previously | 614 |
often | 614 |
flow | 610 |
decreased | 610 |
novel | 609 |
therefore | 606 |
drug | 605 |
csf | 605 |
culture | 605 |
count | 603 |
include | 602 |
haplo | 602 |
mediated | 601 |
combination | 601 |
university | 601 |
myeloablative | 598 |
described | 598 |
agents | 598 |
old | 596 |
seen | 595 |
despite | 594 |
management | 590 |
chimerism | 590 |
tumor | 590 |
auf | 590 |
allograft | 589 |
ric | 589 |
den | 588 |
heart | 585 |
retrospective | 584 |
oral | 584 |
male | 583 |
el | 582 |
poor | 581 |
breast | 581 |
onset | 580 |
assay | 578 |
better | 576 |
therapeutic | 575 |
invasive | 575 |
show | 574 |
like | 572 |
life | 571 |
milk | 571 |
differences | 569 |
tissue | 568 |
bm | 565 |
nicht | 564 |
active | 564 |
required | 563 |
achieved | 563 |
possible | 563 |
criteria | 562 |
proliferation | 561 |
suggest | 560 |
mutations | 559 |
dc | 557 |
prospective | 556 |
source | 555 |
fungal | 554 |
improved | 554 |
obtained | 553 |
evaluation | 553 |
molecular | 550 |
th | 549 |
co | 548 |
medical | 547 |
cytokine | 547 |
als | 544 |
hsv | 544 |
limited | 543 |
line | 542 |
conflict | 542 |
adenovirus | 541 |
large | 540 |
cyclophosphamide | 540 |
relapsed | 540 |
cancer | 540 |
defined | 539 |
immunity | 539 |
testing | 537 |
findings | 536 |
late | 536 |
whether | 534 |
derived | 534 |
many | 533 |
result | 533 |
hhv | 531 |
auch | 531 |
intensity | 530 |
mutation | 529 |
still | 528 |
rna | 526 |
tcr | 524 |
genetic | 523 |
reduction | 523 |
plasma | 522 |
even | 519 |
caused | 518 |
neutrophil | 517 |
previous | 517 |
family | 517 |
introduction | 514 |
loss | 513 |
infusion | 513 |
whereas | 511 |
collected | 511 |
remains | 510 |
experience | 508 |
score | 507 |
method | 506 |
solid | 506 |
approach | 506 |
history | 506 |
antiviral | 503 |
cumulative | 498 |
iii | 497 |
female | 496 |
recurrent | 493 |
cellular | 492 |
infektion | 492 |
resistant | 491 |
might | 491 |
genes | 490 |
occur | 490 |
health | 490 |
grafts | 488 |
expressed | 488 |
frequency | 487 |
least | 486 |
additional | 486 |
especially | 486 |
patienten | 485 |
malignancies | 485 |
course | 484 |
dependent | 484 |
administration | 484 |
zur | 483 |
doses | 481 |
nrm | 481 |
highly | 481 |
mrd | 481 |
vaccination | 479 |
usually | 479 |
events | 478 |
tract | 478 |
centers | 478 |
recent | 476 |
adults | 475 |
sich | 474 |
systemic | 473 |
setting | 473 |
characteristics | 471 |
features | 470 |
via | 470 |
association | 469 |
infant | 468 |
dl | 467 |
five | 467 |
isolated | 467 |
immunoglobulin | 466 |
biopsy | 466 |
assessed | 466 |
myeloid | 465 |
cytometry | 464 |
target | 463 |
safety | 463 |
platelet | 463 |
reconstitution | 462 |
combined | 462 |
duration | 461 |
absence | 459 |
initial | 459 |
prevention | 458 |
sibling | 457 |
diagnostic | 457 |
busulfan | 456 |
stimulation | 456 |
month | 455 |
therapie | 455 |
hcv | 454 |
antigens | 453 |
changes | 452 |
autoimmune | 451 |
sequence | 450 |
controls | 448 |
herpes | 447 |
aim | 446 |
pathogens | 446 |
causes | 446 |
activated | 444 |
cy | 441 |
small | 440 |
involved | 439 |
undergoing | 439 |
proteins | 439 |
value | 437 |
assays | 437 |
confirmed | 436 |
protocol | 436 |
immunosuppressive | 435 |
frequent | 434 |
need | 434 |
presentation | 433 |
support | 431 |
wird | 431 |
prevent | 428 |
igm | 427 |
memory | 426 |
ganciclovir | 425 |
procedure | 421 |
weight | 421 |
determined | 419 |
dli | 418 |
randomized | 416 |
load | 415 |
involvement | 413 |
binding | 413 |
tacrolimus | 412 |
characterized | 411 |
intravenous | 411 |
tbi | 410 |
pt | 409 |
kann | 408 |
ein | 408 |
ratio | 408 |
class | 408 |
laboratory | 407 |
tlr | 407 |
currently | 406 |
body | 405 |
multivariate | 404 |
evaluate | 404 |
adverse | 404 |
tested | 404 |
functional | 403 |
research | 403 |
administered | 402 |
inflammation | 402 |
morbidity | 402 |
infektionen | 402 |
objectives | 401 |
alternative | 400 |
rare | 400 |
independent | 400 |
recently | 400 |
majority | 399 |
scid | 399 |
determine | 399 |
surface | 398 |
likely | 398 |
identify | 398 |
mechanisms | 398 |
regulatory | 398 |
cytokines | 398 |
disorders | 397 |
counts | 397 |
current | 397 |
review | 396 |
monitoring | 396 |
last | 396 |
elevated | 396 |
mobilization | 395 |
mds | 395 |
measured | 394 |
resistance | 394 |
complication | 393 |
affected | 393 |
develop | 392 |
mother | 391 |
stage | 390 |
order | 389 |
individuals | 389 |
vod | 389 |
pfs | 388 |
prolonged | 387 |
sequences | 387 |
fludarabine | 387 |
studied | 387 |
ecp | 386 |
neutropenia | 385 |
trm | 384 |
breastfeeding | 384 |
mechanism | 384 |
lines | 383 |
decrease | 383 |
sepsis | 382 |
later | 382 |
established | 382 |
acquired | 382 |
various | 381 |
wt | 381 |
strategy | 380 |
phenotype | 380 |
depletion | 379 |
provide | 378 |
illness | 378 |
immunocompromised | 377 |
contrast | 376 |
six | 376 |
improve | 375 |
real | 374 |
identical | 374 |
se | 373 |
auto | 372 |
lesions | 372 |
resulted | 371 |
tnf | 370 |
myeloma | 369 |
comparison | 368 |
occurs | 367 |
process | 365 |
mouse | 364 |
improvement | 363 |
good | 363 |
alone | 362 |
investigated | 362 |
plus | 361 |
numbers | 360 |
peptide | 360 |
alive | 360 |
exposure | 360 |
whole | 360 |
declare | 360 |
treg | 359 |
mud | 359 |
mismatched | 358 |
strategies | 357 |
lead | 357 |
daily | 357 |
cyclosporine | 356 |
end | 356 |
progressive | 355 |
able | 354 |
increasing | 350 |
rapid | 350 |
nothing | 350 |
quantitative | 349 |
quality | 348 |
mild | 348 |
unit | 347 |
steroid | 347 |
posttransplant | 346 |
elisa | 346 |
car | 345 |
repertoire | 345 |
sequencing | 345 |
anemia | 344 |
needed | 344 |
tolerance | 344 |
central | 343 |
direct | 343 |
baseline | 343 |
molecules | 341 |
particularly | 340 |
los | 340 |
rsv | 340 |
screening | 340 |
conditions | 339 |
csa | 339 |
reduce | 339 |
dysfunction | 338 |
part | 338 |
values | 338 |
acid | 337 |
del | 337 |
subjects | 337 |
trials | 337 |
mmf | 337 |
pbsc | 336 |
commonly | 336 |
episodes | 335 |
form | 335 |
retrospectively | 334 |
sign | 334 |
full | 334 |
pathway | 334 |
leading | 333 |
resulting | 333 |
complex | 333 |
option | 333 |
main | 333 |
furthermore | 332 |
aids | 332 |
tests | 331 |
lack | 331 |
injury | 330 |
candida | 330 |
hemorrhagic | 330 |
partial | 330 |
consisted | 330 |
van | 329 |
malignant | 329 |
stable | 328 |
ebmt | 328 |
ivig | 327 |
consecutive | 326 |
foxp | 326 |
started | 326 |
generation | 326 |
series | 325 |
manifestations | 324 |
effector | 324 |
drugs | 323 |
intensive | 322 |
bk | 319 |
site | 319 |
cardiac | 318 |
recommended | 317 |
successful | 317 |
frequently | 317 |
hematological | 316 |
vor | 316 |
containing | 316 |
bacteria | 316 |
diarrhea | 315 |
conventional | 314 |
agent | 314 |
apoptosis | 313 |
mhc | 313 |
assess | 313 |
signaling | 313 |
gastrointestinal | 312 |
receptors | 312 |
appropriate | 312 |
expansion | 312 |
week | 311 |
average | 311 |
globulin | 309 |
models | 309 |
general | 308 |
allosct | 308 |
severity | 308 |
ct | 308 |
benefit | 307 |
cultures | 306 |
inhibitors | 306 |
collection | 306 |
selection | 305 |
generated | 305 |
analyses | 304 |
selected | 304 |
experienced | 303 |
mixed | 303 |
rituximab | 303 |
made | 302 |
information | 302 |
short | 302 |
clinically | 302 |
correlation | 301 |
aspergillus | 300 |
comparable | 300 |
organs | 300 |
persistent | 299 |
moreover | 299 |
macrophages | 298 |
demonstrate | 298 |
reports | 298 |
monoclonal | 297 |
developing | 297 |
key | 296 |
guidelines | 296 |
inhibitor | 295 |
bmt | 295 |
advanced | 295 |
induce | 293 |
variable | 293 |
viremia | 292 |
melphalan | 292 |
growth | 291 |
extensive | 290 |
hbv | 290 |
ng | 290 |
tuberculosis | 290 |
linked | 289 |
subsets | 289 |
st | 288 |
another | 288 |
markers | 288 |
size | 288 |
disseminated | 288 |
prevalence | 287 |
underlying | 287 |
longer | 286 |
vaccines | 286 |
correlated | 286 |
prognosis | 286 |
varicella | 286 |
ra | 286 |
greater | 285 |
older | 285 |
statistically | 285 |
moderate | 284 |
ptcy | 284 |
vector | 283 |
controlled | 283 |
types | 282 |
double | 282 |
dem | 281 |
documented | 281 |
differentiation | 280 |
icu | 279 |
therapies | 279 |
regarding | 278 |
regulation | 278 |
ptld | 278 |
steroids | 277 |
date | 277 |
mainly | 277 |
safe | 276 |
work | 276 |
remained | 276 |
protective | 275 |
release | 275 |
pr | 275 |
ability | 274 |
cytotoxic | 274 |
seven | 273 |
bkv | 273 |
infused | 273 |
now | 272 |
por | 272 |
eight | 272 |
bu | 272 |
subsequent | 272 |
signs | 272 |
capacity | 271 |
pain | 271 |
suggesting | 271 |
sensitivity | 270 |
hepatic | 270 |
species | 270 |
prognostic | 270 |
every | 270 |
stimulated | 269 |
reaction | 269 |
third | 267 |
parameters | 267 |
produced | 267 |
influence | 266 |
procedures | 266 |
us | 266 |
depleted | 265 |
hours | 265 |
times | 264 |
identification | 264 |
optimal | 264 |
zoster | 264 |
chain | 263 |
indicated | 263 |
fold | 262 |
biopsies | 262 |
side | 261 |
products | 261 |
unknown | 261 |
particular | 260 |
gram | 260 |
point | 260 |
event | 259 |
sowie | 259 |
aus | 259 |
women | 258 |
deficient | 258 |
hematologic | 258 |
receive | 257 |
vzv | 257 |
assessment | 257 |
estimated | 256 |
registry | 256 |
maintenance | 256 |
gamma | 256 |
nhl | 255 |
thrombocytopenia | 255 |
ig | 255 |
prophylactic | 255 |
natural | 254 |
generally | 254 |
product | 253 |
min | 253 |
spectrum | 253 |
region | 252 |
potentially | 252 |
seropositive | 252 |
shock | 251 |
cystitis | 251 |
approximately | 251 |
pattern | 251 |
tx | 250 |
statistical | 250 |
child | 249 |
allografts | 249 |
antibiotics | 249 |
murine | 249 |
local | 248 |
immunological | 248 |
endothelial | 248 |
salvage | 247 |
occurrence | 247 |
intestinal | 247 |
membrane | 247 |
disorder | 246 |
malignancy | 246 |
authors | 246 |
pneumocystis | 246 |
impaired | 246 |
replication | 246 |
colitis | 246 |
fi | 246 |
cgd | 245 |
play | 245 |
contact | 245 |
indicate | 244 |
published | 244 |
expressing | 243 |
sample | 243 |
beta | 241 |
pid | 241 |
practice | 241 |
gi | 241 |
dendritic | 241 |
bis | 241 |
curative | 241 |
con | 241 |
january | 240 |
tissues | 240 |
analysed | 240 |
cidofovir | 240 |
populations | 240 |
individual | 240 |
necessary | 240 |
essential | 240 |
investigate | 239 |
damage | 239 |
terms | 238 |
applied | 237 |
nd | 237 |
un | 237 |
mycophenolate | 237 |
lymphoproliferative | 237 |
antibiotic | 236 |
concentration | 236 |
proportion | 236 |
ex | 236 |
diagnose | 235 |
nur | 235 |
ab | 235 |
best | 234 |
bal | 234 |
epithelial | 234 |
attention | 234 |
ul | 234 |
serious | 234 |
transfer | 234 |
variant | 233 |
fatal | 233 |
ca | 233 |
mothers | 233 |
protection | 233 |
successfully | 233 |
cvid | 233 |
young | 233 |
states | 232 |
set | 232 |
organisms | 232 |
critical | 232 |
finally | 232 |
inhibition | 232 |
percentage | 232 |
state | 232 |
probability | 231 |
towards | 231 |
performance | 231 |
intracellular | 231 |
treat | 231 |
iga | 230 |
remain | 230 |
immunization | 230 |
see | 230 |
sirolimus | 230 |
regression | 230 |
abnormalities | 230 |
others | 229 |
mrna | 229 |
pathogen | 229 |
led | 229 |
minimal | 229 |
lt | 229 |
interaction | 229 |
dcs | 228 |
enrolled | 227 |
twenty | 227 |
msd | 227 |
pb | 227 |
copies | 227 |
suppression | 227 |
must | 226 |
antifungal | 226 |
relative | 226 |
countries | 226 |
significance | 226 |
requiring | 226 |
conducted | 226 |
cross | 226 |
urine | 225 |
literature | 225 |
complement | 225 |
tb | 225 |
relevant | 224 |
diffuse | 224 |
interferon | 223 |
animals | 223 |
promoter | 223 |
presenting | 223 |
international | 223 |
targeted | 223 |
staining | 222 |
fluid | 222 |
program | 222 |
admission | 222 |
transfusion | 222 |
continued | 221 |
national | 221 |
change | 221 |
neutrophils | 221 |
interstitial | 220 |
tregs | 220 |
experimental | 220 |
opportunistic | 220 |
variants | 220 |
delayed | 219 |
shows | 219 |
areas | 219 |
elderly | 219 |
become | 219 |
epstein | 218 |
proven | 218 |
barr | 218 |
gut | 218 |
additionally | 218 |
profile | 218 |
replacement | 217 |
united | 217 |
volume | 217 |
self | 217 |
department | 217 |
plerixafor | 217 |
innate | 217 |
stat | 217 |
interestingly | 217 |
importance | 216 |
enhanced | 216 |
suspected | 216 |
flu | 216 |
together | 215 |
encephalitis | 215 |
yet | 215 |
affect | 215 |
necrosis | 215 |
help | 214 |
points | 214 |
msc | 214 |
predictive | 214 |
mononuclear | 214 |
index | 214 |
wie | 213 |
yrs | 213 |
fibrosis | 213 |
ventilation | 212 |
suggested | 212 |
gd | 212 |
ms | 212 |
except | 211 |
isolation | 211 |
aa | 211 |
pneumoniae | 211 |
monocytes | 211 |
community | 211 |
cost | 211 |
hl | 211 |
useful | 211 |
seems | 210 |
formation | 210 |
objective | 210 |
beam | 210 |
remaining | 210 |
pro | 209 |
describe | 209 |
aged | 209 |
measles | 209 |
subsequently | 208 |
concentrations | 208 |
specificity | 208 |
po | 208 |
relatively | 207 |
approved | 207 |
titers | 207 |
recognized | 206 |
dfs | 206 |
transcription | 206 |
examined | 206 |
deaths | 206 |
ctla | 206 |
allohsct | 206 |
sites | 206 |
suggests | 206 |
resolution | 205 |
centre | 205 |
provided | 205 |
noted | 205 |
consistent | 205 |
alpha | 204 |
einem | 204 |
absolute | 204 |
institute | 204 |
ribavirin | 204 |
ongoing | 204 |
length | 203 |
contribute | 203 |
reached | 203 |
germany | 203 |
id | 203 |
spleen | 203 |
application | 203 |
promising | 202 |
institution | 202 |
herpesvirus | 202 |
initiation | 202 |
amphotericin | 202 |
world | 202 |
multi | 201 |
specimens | 201 |
brain | 201 |
simplex | 201 |
irradiation | 200 |
distribution | 200 |
intermediate | 200 |
added | 200 |
functions | 200 |
routine | 200 |
sex | 200 |
physical | 200 |
interactions | 199 |
recombinant | 199 |
rt | 199 |
compare | 199 |
pd | 198 |
met | 198 |
variables | 198 |
signal | 198 |
already | 197 |
upper | 197 |
thymic | 197 |
susceptibility | 197 |
mofetil | 196 |
failed | 196 |
strains | 196 |
ad | 196 |
sensitive | 195 |
apheresis | 195 |
gegen | 195 |
maternal | 195 |
chest | 195 |
peptides | 195 |
secretion | 195 |
fully | 194 |
univariate | 194 |
problem | 194 |
mac | 194 |
ccr | 194 |
lymphopenia | 194 |
distinct | 194 |
reviewed | 193 |
antimicrobial | 193 |
tolerated | 193 |
lymphoid | 193 |
purified | 193 |
efs | 193 |
weekly | 192 |
highest | 192 |
alemtuzumab | 192 |
tma | 192 |
treatments | 192 |
surgical | 192 |
valganciclovir | 192 |
fl | 192 |
nine | 191 |
confirm | 191 |
acyclovir | 190 |
done | 190 |
lfs | 190 |
feasible | 190 |
apoptotic | 189 |
een | 189 |
immunotherapy | 189 |
search | 189 |
calculated | 189 |
interval | 188 |
excluded | 188 |
future | 188 |
isolates | 188 |
marker | 188 |
basis | 188 |
mscs | 187 |
creatinine | 187 |
medicine | 186 |
infusions | 186 |
keine | 186 |
pathogenesis | 186 |
polymerase | 186 |
expanded | 186 |
strong | 185 |
expected | 185 |
aspergillosis | 185 |
nephropathy | 185 |
starting | 185 |
sos | 185 |
abnormal | 185 |
adv | 185 |
initiated | 185 |
platelets | 185 |
genome | 185 |
kinase | 184 |
rash | 184 |
pneumonitis | 184 |
defects | 184 |
pressure | 184 |
clear | 183 |
airway | 183 |
residual | 183 |
rag | 183 |
dengue | 183 |
surgery | 183 |
left | 183 |
appears | 182 |
tumors | 182 |
hlh | 182 |
males | 182 |
corticosteroids | 182 |
pregnancy | 182 |
haematopoietic | 182 |
vascular | 181 |
methotrexate | 181 |
survey | 181 |
pacientes | 181 |
earlier | 181 |
asymptomatic | 181 |
examination | 181 |
patterns | 181 |
abdominal | 181 |
pathogenic | 180 |
multicenter | 180 |
producing | 180 |
degree | 180 |
comparing | 180 |
aureus | 180 |
properties | 180 |
heterozygous | 180 |
challenge | 180 |
diabetes | 180 |
causing | 179 |
far | 179 |
require | 179 |
sustained | 179 |
hematology | 179 |
detect | 179 |
arm | 179 |
imaging | 178 |
difficult | 178 |
microscopy | 178 |
represent | 178 |
almost | 178 |
bl | 178 |
hospitalization | 178 |
approaches | 178 |
pathology | 177 |
larger | 177 |
immunology | 177 |
broad | 177 |
ruxolitinib | 177 |
iu | 177 |
preemptive | 176 |
directly | 176 |
nachweis | 176 |
initially | 176 |
leads | 176 |
classification | 176 |
along | 176 |
strain | 176 |
vectors | 175 |
next | 175 |
reactive | 175 |
relationship | 175 |
hc | 174 |
survivors | 174 |
provides | 174 |
circulating | 174 |
cycle | 174 |
ligand | 174 |
het | 174 |
allows | 174 |
balb | 173 |
pp | 173 |
cns | 173 |
humans | 173 |
hand | 173 |
pi | 173 |
red | 173 |
increases | 173 |
nf | 173 |
occurring | 173 |
monitored | 173 |
targeting | 173 |
neutropenic | 173 |
enzyme | 172 |
congenital | 172 |
genotype | 172 |
calcineurin | 172 |
febrile | 172 |
area | 172 |
aber | 172 |
sdc | 172 |
latent | 172 |
typically | 172 |
regions | 171 |
cultured | 171 |
wild | 170 |
modified | 170 |
gender | 170 |
achieve | 170 |
experiments | 169 |
lymph | 169 |
twice | 168 |
humoral | 168 |
art | 168 |
certain | 168 |
burden | 168 |
restricted | 167 |
nkt | 167 |
younger | 167 |
females | 167 |
usa | 167 |
thiotepa | 167 |
cap | 167 |
ns | 167 |
sie | 166 |
start | 166 |
mab | 166 |
mismatch | 166 |
adoptive | 165 |
indicating | 165 |
maturation | 165 |
una | 165 |
typical | 165 |
lungs | 164 |
meist | 164 |
consolidation | 164 |
risks | 164 |
threatening | 164 |
units | 163 |
trend | 163 |
ten | 163 |
hodgkin | 163 |
recommendations | 163 |
inkt | 163 |
condition | 163 |
panel | 163 |
exposed | 163 |
recognition | 163 |
zum | 163 |
pcp | 162 |
potent | 162 |
specifically | 162 |
analyze | 162 |
islet | 162 |
hypogammaglobulinemia | 162 |
bzw | 162 |
choice | 162 |
trasplante | 161 |
rather | 161 |
represents | 161 |
preventing | 161 |
origin | 161 |
signifi | 161 |
preliminary | 160 |
ige | 160 |
rapidly | 160 |
protocols | 160 |
techniques | 160 |
staphylococcus | 160 |
dass | 160 |
parainfluenza | 160 |
ahsct | 160 |
autoimmunity | 160 |
pg | 159 |
crucial | 159 |
express | 159 |
ifng | 159 |
donation | 159 |
cycles | 159 |
across | 159 |
engrafted | 158 |
recurrence | 158 |
requires | 158 |
subset | 158 |
fluconazole | 158 |
cm | 158 |
auc | 158 |
inclusion | 158 |
ph | 157 |
letermovir | 157 |
aimed | 156 |
ko | 156 |
tgf | 156 |
kommt | 156 |
ctl | 156 |
erreger | 156 |
treosulfan | 156 |
produce | 155 |
infiltration | 155 |
ha | 155 |
immunocompetent | 155 |
predict | 155 |
responsible | 155 |
mitochondria | 155 |
novo | 154 |
foscarnet | 154 |
knowledge | 154 |
pet | 154 |
leukaemia | 154 |
includes | 154 |
december | 153 |
transient | 153 |
delivery | 153 |
mtx | 153 |
domain | 153 |
observation | 153 |
animal | 153 |
candidiasis | 152 |
rarely | 152 |
era | 152 |
consensus | 152 |
surveillance | 152 |
half | 152 |
placebo | 152 |
childhood | 152 |
symptomatic | 151 |
detectable | 151 |
european | 151 |
cml | 151 |
transferred | 151 |
understanding | 151 |
bronchiolitis | 151 |
unter | 151 |
aplastic | 151 |
sehr | 151 |
unclear | 151 |
variety | 151 |
showing | 151 |
taken | 150 |
coli | 150 |
fieber | 150 |
pathways | 150 |
gr | 150 |
flt | 150 |
persons | 150 |
forms | 149 |
infiltrates | 149 |
india | 149 |
scores | 149 |
urinary | 149 |
bcl | 149 |
intervention | 149 |
hypertension | 148 |
sd | 148 |
lps | 148 |
peak | 148 |
htlv | 148 |
parents | 148 |
deletion | 148 |
efficient | 147 |
specifi | 147 |
signals | 147 |
ada | 147 |
mostly | 147 |
las | 147 |
similarly | 147 |
colonization | 147 |
indication | 147 |
mcl | 147 |
log | 147 |
example | 146 |
molecule | 146 |
focal | 146 |
cox | 146 |
little | 146 |
deeprc | 146 |
medium | 146 |
database | 145 |
candidates | 145 |
cohorts | 145 |
immunologic | 145 |
right | 145 |
pneumococcal | 145 |
hsc | 145 |
toxic | 145 |
processes | 145 |
systems | 145 |
living | 144 |
affecting | 144 |
though | 144 |
meningitis | 143 |
kidneys | 143 |
migration | 143 |
syncytial | 143 |
gy | 143 |
mechanical | 143 |
depending | 142 |
toxicities | 142 |
repertoires | 142 |
kir | 142 |
options | 142 |
voriconazole | 142 |
became | 142 |
predominantly | 142 |
members | 142 |
supported | 141 |
carried | 141 |
nl | 141 |
tage | 141 |
allele | 141 |
les | 141 |
mature | 141 |
bacteremia | 141 |
learning | 141 |
le | 141 |
society | 140 |
wide | 140 |
medications | 140 |
man | 140 |
phosphorylation | 140 |
media | 140 |
continuous | 140 |
worse | 140 |
context | 140 |
purpose | 139 |
atypical | 139 |
probably | 139 |
blasts | 139 |
cb | 139 |
tool | 139 |
network | 139 |
extended | 139 |
mass | 138 |
much | 138 |
adequate | 138 |
nih | 138 |
lymphoblastic | 138 |
defect | 138 |
plasmid | 138 |
parvovirus | 138 |
supportive | 138 |
summary | 138 |
western | 137 |
dr | 137 |
directed | 137 |
clearance | 137 |
nkg | 137 |
gp | 137 |
referred | 137 |
unique | 136 |
responders | 136 |
allohct | 136 |
epidemiology | 136 |
nature | 136 |
adjusted | 136 |
mucositis | 136 |
mri | 136 |
live | 136 |
sufficient | 136 |
etiology | 136 |
ctls | 136 |
untreated | 135 |
sle | 135 |
tac | 135 |
targets | 135 |
final | 135 |
american | 135 |
interleukin | 135 |
ards | 135 |
technique | 135 |
diese | 135 |
responded | 135 |
cytotoxicity | 134 |
materials | 134 |
differ | 134 |
zellen | 134 |
tki | 134 |
inhibitory | 134 |
cll | 134 |
strongly | 133 |
amino | 133 |
marked | 133 |
fact | 133 |
scd | 133 |
regulated | 133 |
calcium | 133 |
measures | 133 |
ag | 133 |
cutaneous | 133 |
coronavirus | 133 |
eines | 132 |
bos | 132 |
ligands | 132 |
allow | 132 |
transmitted | 132 |
reactions | 132 |
seronegative | 132 |
investigation | 132 |
nuclear | 132 |
injection | 132 |
problems | 132 |
killer | 131 |
newly | 131 |
ibd | 131 |
discontinued | 131 |
rr | 131 |
sars | 131 |
stay | 131 |
sources | 131 |
antiretroviral | 131 |
erkrankung | 131 |
validation | 131 |
newborn | 130 |
histological | 130 |
absent | 130 |
ar | 130 |
kb | 130 |
respond | 130 |
bleeding | 129 |
aggressive | 129 |
para | 129 |
widely | 129 |
divided | 129 |
implanted | 129 |
malaria | 129 |
yield | 129 |
syndromes | 128 |
percent | 128 |
beneficial | 128 |
centres | 128 |
symptome | 128 |
step | 128 |
umbilical | 128 |
mycobacterium | 128 |
differential | 128 |
superior | 127 |
eligible | 127 |
leukocyte | 127 |
working | 127 |
processing | 127 |
mel | 127 |
treating | 127 |
mucosal | 127 |
mo | 127 |
update | 127 |
ischemia | 126 |
sp | 126 |
involving | 126 |
spp | 126 |
epitope | 126 |
er | 126 |
pretransplant | 126 |
cni | 126 |
auftreten | 126 |
indications | 126 |
consisting | 125 |
consider | 125 |
genomic | 125 |
thalassemia | 125 |
tag | 125 |
technology | 125 |
possibility | 125 |
amount | 125 |
conditioned | 125 |
maximum | 125 |
adaptive | 124 |
beyond | 124 |
predicted | 124 |
proposed | 124 |
alveolar | 124 |
altered | 124 |
abo | 124 |
complicated | 124 |
stress | 124 |
impairment | 124 |
biological | 124 |
infl | 123 |
arthritis | 123 |
ta | 123 |
susceptible | 123 |
recorded | 123 |
mitochondrial | 123 |
alloreactive | 123 |
appear | 123 |
bowel | 123 |
discontinuation | 123 |
cut | 123 |
reference | 123 |
clinic | 122 |
respect | 122 |
fc | 122 |
ucb | 122 |
june | 122 |
ed | 122 |
soluble | 121 |
einen | 121 |
sera | 121 |
past | 121 |
maintained | 121 |
terminal | 121 |
rd | 121 |
stages | 121 |
wbc | 121 |
delay | 121 |
close | 121 |
excellent | 120 |
transfusions | 120 |
dsa | 120 |
ranging | 120 |
repeated | 120 |
kit | 120 |
pairs | 120 |
neonatal | 120 |
yellow | 120 |
reducing | 119 |
designed | 119 |
progress | 119 |
haart | 119 |
substantial | 119 |
jedoch | 119 |
characteristic | 119 |
mobilized | 119 |
transgenic | 119 |
encoding | 118 |
allogenic | 118 |
west | 118 |
corresponding | 118 |
open | 118 |
chimeric | 118 |
access | 118 |
resolved | 118 |
efficiency | 118 |
fungi | 118 |
tumour | 118 |
leukemic | 117 |
generate | 117 |
journal | 117 |
titer | 117 |
reasons | 117 |
immunodeficiencies | 117 |
organism | 117 |
olt | 117 |
scale | 117 |
clearly | 117 |
completely | 116 |
markedly | 116 |
qol | 116 |
bp | 116 |
records | 116 |
naive | 116 |
throughout | 116 |
primarily | 116 |
november | 116 |
concern | 115 |
ferritin | 115 |
global | 115 |
rst | 115 |
yr | 115 |
pbmcs | 115 |
design | 115 |
kindern | 115 |
progenitor | 115 |
motif | 115 |
macrophage | 115 |
siblings | 115 |
favorable | 115 |
um | 115 |
septic | 114 |
finding | 114 |
gain | 114 |
light | 114 |
around | 114 |
spread | 114 |
suitable | 114 |
da | 114 |
classified | 114 |
cytogenetic | 114 |
signalling | 114 |
manifestation | 113 |
success | 113 |
characterization | 113 |
cure | 113 |
establish | 113 |
neurological | 113 |
selective | 113 |
allowed | 113 |
components | 113 |
hypothesis | 113 |
undergo | 113 |
thirty | 113 |
birth | 113 |
gfr | 113 |
myelodysplastic | 113 |
thought | 112 |
ucbt | 112 |
immunosuppressed | 112 |
party | 112 |
hsp | 112 |
card | 112 |
gt | 112 |
episode | 112 |
reduces | 112 |
bilateral | 112 |
considering | 112 |
mir | 112 |
homozygous | 112 |
pancreas | 112 |
possibly | 112 |
dosing | 111 |
cxcr | 111 |
fraction | 111 |
clones | 111 |
retinitis | 111 |
defibrotide | 111 |
continue | 111 |
anc | 111 |
prospectively | 111 |
behandlung | 110 |
impfung | 110 |
cryopreserved | 110 |
diagnostik | 110 |
datasets | 110 |
sein | 110 |
sollte | 110 |
timing | 110 |
meld | 110 |
completed | 110 |
note | 110 |
tcd | 110 |
tubular | 109 |
inhibited | 109 |
sub | 109 |
om | 109 |
dysregulation | 109 |
tratamiento | 109 |
besteht | 109 |
hscs | 109 |
transplantations | 109 |
sot | 109 |
selten | 109 |
ae | 109 |
thymocyte | 109 |
settings | 109 |
etoposide | 109 |
diversity | 109 |
dominant | 108 |
gm | 108 |
viren | 108 |
committee | 108 |
admitted | 108 |
anderen | 108 |
component | 108 |
wurden | 108 |
importantly | 108 |
hd | 108 |
hazard | 108 |
dataset | 108 |
hpv | 108 |
detailed | 108 |
causative | 108 |
asthma | 108 |
lacking | 108 |
trimethoprim | 108 |
doi | 107 |
enhance | 107 |
depends | 107 |
men | 107 |
match | 107 |
endpoint | 107 |
allergic | 107 |
bcr | 107 |
ova | 107 |
haematological | 107 |
availability | 107 |
avoid | 107 |
reperfusion | 106 |
neither | 106 |
cp | 106 |
recovered | 106 |
proteinuria | 106 |
je | 106 |
networks | 106 |
erkrankungen | 106 |
nodes | 106 |
suffered | 106 |
nod | 106 |
uid | 106 |
device | 106 |
autosomal | 106 |
epitopes | 106 |
acceptable | 106 |
dlbcl | 106 |
lymphocytic | 106 |
hbsag | 106 |
way | 105 |
thymus | 105 |
input | 105 |
focus | 105 |
manner | 105 |
poorly | 105 |
plays | 105 |
immediately | 105 |
periods | 105 |
reverse | 105 |
andere | 105 |
white | 105 |
nervous | 105 |
minor | 105 |
sr | 105 |
thereby | 105 |
mucosa | 105 |
lymphomas | 105 |
always | 105 |
cardiovascular | 104 |
ri | 104 |
largely | 104 |
obtain | 104 |
emerging | 104 |
contribution | 104 |
trec | 104 |
ill | 104 |
immunomodulatory | 104 |
bohv | 104 |
rptec | 104 |
cxcl | 104 |
indirect | 104 |
grfs | 104 |
viability | 104 |
indicates | 104 |
particles | 104 |
entire | 104 |
endemic | 104 |
venous | 104 |
kommen | 104 |
europe | 104 |
streptococcus | 103 |
rank | 103 |
nephritis | 103 |
wurde | 103 |
klinische | 103 |
kinetics | 103 |
nm | 103 |
granulomatous | 102 |
pseudomonas | 102 |
accompanied | 102 |
instance | 102 |
material | 102 |
ifi | 102 |
concomitant | 102 |
decline | 102 |
mabs | 102 |
measure | 102 |
mycoplasma | 102 |
concerning | 102 |
wochen | 102 |
exome | 102 |
field | 102 |
metabolic | 102 |
conclude | 102 |
lavage | 102 |
ia | 102 |
transduction | 102 |
make | 101 |
iqr | 101 |
affects | 101 |
hat | 101 |
transduced | 101 |
unmanipulated | 101 |
rotavirus | 101 |
environment | 101 |
define | 101 |
como | 101 |
gvl | 101 |
noch | 101 |
medication | 101 |
interventions | 101 |
wound | 101 |
induces | 101 |
beim | 101 |
diagnoses | 101 |
october | 101 |
emptive | 101 |
cdc | 101 |
appearance | 100 |
fusion | 100 |
july | 100 |
oxygen | 100 |
account | 100 |
whose | 100 |
paediatric | 100 |
employed | 100 |
erfolgt | 100 |
distress | 100 |
sequential | 100 |
abs | 100 |
inhibit | 99 |
critically | 99 |
action | 99 |
needs | 99 |
cytopenias | 99 |
limitations | 99 |
proliferative | 99 |
cbt | 99 |
title | 99 |
home | 99 |
blockade | 99 |
insulin | 99 |
matching | 99 |
appeared | 99 |
inferior | 99 |
candidate | 99 |
doc | 98 |
ranged | 98 |
pbmc | 98 |
oncology | 98 |
serology | 98 |
prediction | 98 |
goal | 98 |
hemorrhage | 98 |
worden | 98 |
feeding | 98 |
preparation | 98 |
decreasing | 98 |
water | 98 |
sha | 98 |
suppressive | 98 |
toxoplasmosis | 98 |
seem | 98 |
tetanus | 98 |
kaplan | 98 |
nevertheless | 98 |
muss | 98 |
edema | 98 |
corticosteroid | 98 |
deep | 98 |
premature | 98 |
maribavir | 98 |
discussed | 97 |
reason | 97 |
antithymocyte | 97 |
profound | 97 |
tc | 97 |
extracted | 97 |
nucleic | 97 |
rapamycin | 97 |
albumin | 97 |
mnc | 97 |
toxin | 97 |
allem | 97 |
spontaneous | 97 |
abstract | 97 |
enfermedad | 96 |
implicated | 96 |
tandem | 96 |
increasingly | 96 |
hence | 96 |
reach | 96 |
mesenchymal | 96 |
ma | 96 |
mutant | 96 |
empiric | 96 |
carinii | 96 |
incidences | 96 |
survived | 96 |
immediate | 96 |
extremely | 96 |
zwischen | 96 |
bmi | 96 |
hosts | 96 |
act | 95 |
situation | 95 |
menschen | 95 |
recruitment | 95 |
content | 95 |
catheter | 95 |
adhesion | 95 |
effectiveness | 95 |
competing | 95 |
transfected | 95 |
vaccinated | 95 |
loads | 95 |
leukocytes | 95 |
frequencies | 95 |
lipid | 95 |
dock | 95 |
prepared | 95 |
relapses | 95 |
independently | 95 |
image | 95 |
aeruginosa | 95 |
cytogenetics | 95 |
evaluable | 94 |
contain | 94 |
japan | 94 |
hospitalized | 94 |
routinely | 94 |
muscle | 94 |
suffering | 94 |
mycobacterial | 94 |
colony | 94 |
immunoglobulins | 94 |
measurement | 94 |
dialysis | 94 |
food | 94 |
complexes | 94 |
alle | 94 |
ud | 94 |
quantification | 94 |
implications | 93 |
saa | 93 |
obstruction | 93 |
adenoviral | 93 |
biomarkers | 93 |
uncommon | 93 |
stool | 93 |
motifs | 93 |
uk | 93 |
stimulating | 93 |
jahren | 93 |
people | 93 |
lmp | 93 |
fluorescence | 93 |
lymphadenopathy | 93 |
submitted | 93 |
helper | 93 |
reactivity | 93 |
immunized | 93 |
vd | 93 |
deficiencies | 93 |
discharge | 93 |
elispot | 92 |
neutralizing | 92 |
fast | 92 |
probable | 92 |
introduced | 92 |
solution | 92 |
classical | 92 |
hypothesized | 92 |
category | 92 |
veno | 92 |
adherence | 92 |
rfs | 92 |
proteasome | 92 |
predictors | 92 |
affinity | 92 |
demonstrates | 92 |
simultaneously | 92 |
influenced | 92 |
evaluating | 92 |
apc | 92 |
training | 91 |
physicians | 91 |
cik | 91 |
worldwide | 91 |
na | 91 |
persistence | 91 |
histology | 91 |
iron | 91 |
ir | 91 |
minutes | 91 |
instances | 91 |
electron | 91 |
jak | 91 |
acids | 91 |
cough | 91 |
limit | 91 |
definitive | 91 |
latter | 91 |
op | 91 |
pdc | 91 |
lineage | 91 |
born | 91 |
chromosome | 91 |
injected | 90 |
srl | 90 |
bcg | 90 |
consideration | 90 |
mast | 90 |
registered | 90 |
enriched | 90 |
participants | 90 |
label | 90 |
insbesondere | 90 |
incubated | 90 |
sulfamethoxazole | 90 |
amplification | 89 |
decision | 89 |
subgroup | 89 |
screened | 89 |
aplasia | 89 |
bortezomib | 89 |
million | 89 |
islets | 89 |
lc | 89 |
section | 89 |
nausea | 89 |
march | 89 |
dmso | 89 |
mittels | 89 |
prednisone | 89 |
variability | 89 |
measurements | 89 |
changed | 89 |
riesgo | 89 |
validated | 89 |
plant | 89 |
facs | 89 |
regardless | 89 |
comorbidities | 89 |
consent | 88 |
wenn | 88 |
cant | 88 |
functioning | 88 |
understand | 88 |
regard | 88 |
exact | 88 |
promote | 88 |
cs | 88 |
closely | 88 |
discussion | 88 |
treten | 88 |
jirovecii | 88 |
systematic | 88 |
displayed | 88 |
outbreaks | 88 |
nosocomial | 88 |
providing | 88 |
gb | 88 |
minimum | 88 |
meier | 88 |
granulocyte | 88 |
subcutaneous | 88 |
achieving | 87 |
shorter | 87 |
accumulation | 87 |
perform | 87 |
advantage | 87 |
rise | 87 |
exhibited | 87 |
undergone | 86 |
bij | 86 |
improving | 86 |
limiting | 86 |
feasibility | 86 |
rabbit | 86 |
nct | 86 |
rat | 86 |
killing | 86 |
haben | 86 |
prominent | 86 |
incubation | 86 |
serve | 86 |
correlate | 86 |
attributed | 86 |
symptom | 86 |
isolate | 86 |
surviving | 86 |
characterize | 86 |
courses | 86 |
aufgrund | 85 |
find | 85 |
chemokines | 85 |
software | 85 |
carcinoma | 85 |
delta | 85 |
imatinib | 85 |
structure | 85 |
toxoplasma | 85 |
nile | 85 |
tg | 85 |
kinder | 85 |
occlusive | 85 |
komplikationen | 85 |
hcov | 85 |
called | 84 |
breastfed | 84 |
inclusions | 84 |
evolution | 84 |
taking | 84 |
serologic | 84 |
undetectable | 84 |
extracellular | 84 |
klinischen | 84 |
otherwise | 84 |
fixed | 84 |
cryopreservation | 84 |
polyclonal | 84 |
understood | 84 |
vomiting | 84 |
cytarabine | 84 |
switched | 84 |
polyomavirus | 84 |
partially | 84 |
neurologic | 84 |
processed | 84 |
question | 84 |
gibt | 84 |
eingesetzt | 84 |
clinicians | 84 |
warranted | 83 |
domains | 83 |
reactivations | 83 |
september | 83 |
existing | 83 |
composition | 83 |
monocyte | 83 |
rs | 83 |
synthesis | 83 |
issue | 83 |
contains | 83 |
april | 83 |
means | 83 |
positivity | 83 |
issues | 83 |
nucleotide | 83 |
extracorporeal | 83 |
klinisch | 83 |
cold | 83 |
sclerosis | 83 |
activities | 83 |
tk | 83 |
threshold | 83 |
jahre | 82 |
declared | 82 |
pnh | 82 |
defi | 82 |
person | 82 |
lesion | 82 |
gabe | 82 |
biology | 82 |
platform | 82 |
follows | 82 |
leaf | 82 |
instead | 82 |
immunogenicity | 82 |
profiles | 82 |
adolescents | 82 |
glomerular | 82 |
metapneumovirus | 82 |
vancomycin | 82 |
phenotypes | 82 |
logistic | 82 |
recommend | 82 |
place | 82 |
fresh | 82 |
simultaneous | 82 |
curve | 82 |
hdt | 82 |
immunohistochemistry | 82 |
replete | 82 |
involves | 82 |
myelofibrosis | 82 |
modern | 82 |
crp | 82 |
great | 82 |
urd | 81 |
informed | 81 |
team | 81 |
ranges | 81 |
serotypes | 81 |
grades | 81 |
italy | 81 |
sputum | 81 |
postoperative | 81 |
phenotypic | 81 |
glucose | 81 |
position | 81 |
hemolytic | 81 |
simple | 81 |
intervals | 81 |
antigenic | 81 |
priming | 81 |
categories | 81 |
depression | 81 |
occasionally | 81 |
maintain | 81 |
mdc | 81 |
lost | 81 |
repeat | 81 |
bv | 81 |
aprv | 80 |
sarcoma | 80 |
driven | 80 |
obliterans | 80 |
extent | 80 |
slightly | 80 |
dieser | 80 |
pregnant | 80 |
blind | 80 |
allowing | 80 |
notably | 80 |
immature | 80 |
forty | 80 |
colon | 80 |
nr | 80 |
neg | 80 |
respective | 80 |
autoantibodies | 80 |
accepted | 80 |
mode | 79 |
differentiated | 79 |
list | 79 |
vary | 79 |
institutional | 79 |
intravenously | 79 |
waiting | 79 |
mrsa | 79 |
ie | 79 |
alter | 79 |
original | 79 |
schweren | 79 |
presents | 79 |
inducing | 79 |
consists | 79 |
meta | 79 |
pneumonias | 79 |
itd | 79 |
tnc | 79 |
ef | 79 |
exist | 79 |
contamination | 79 |
pos | 79 |
cdna | 79 |
scan | 79 |
eleven | 79 |
varied | 78 |
plants | 78 |
trough | 78 |
stained | 78 |
suggestive | 78 |
progressed | 78 |
lupus | 78 |
amounts | 78 |
fda | 78 |
leukopenia | 78 |
pneumonie | 78 |
aspects | 78 |
blot | 78 |
explain | 78 |
proved | 78 |
withdrawal | 78 |
attenuated | 78 |
verlauf | 78 |
caspase | 78 |